Click here to return to the homepage.
Maryland Crown Logo Governor Martin O’Malley and Lt. Governor Anthony G. Brown
 Contact Us Search:  
EDCP Home

EDCP Mission/Vision

Fact Sheets
Guidelines
Case Report Forms
Hepatitis C
Immunization
Influenza
Outbreak Investigation
Sexually Transmitted Diseases
Tuberculosis Control
Zoonotic and Vector-borne Diseases
Lyme Disease
Emerging Infections Program
ImmuNet
Reportable Diseases: What to Report
Reportable Diseases: Counts and Rates

Methicillin-resistant
Staphylococcus aureus

(MRSA)

Methicillin-resistant

Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium that causes various types of infections.  Due to its increased resistance to certain antibiotics, MRSA infections have become more difficult to treat.  MRSA is spread person-to-person through direct contact.

MRSA is most common among those with lowered immunity and have a history of hospitalization, recent medical procedure, or nursing home residency.  Studies have shown that nosocomial or healthcare-associated (HA)-MRSA infection is on the rise.  In intensive care units (ICUs) at hospitals participating in the National Healthcare Safety Network (NHSN), the mean percentage of S. aureus isolates that were MRSA increased from 2.4% in 1975 to 29% in 1991 and to 51.3% in 2002.1 

In addition to this increase in healthcare settings, MRSA is emerging as an important pathogen in the community as well.  MRSA infections that occur in healthy individuals who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as community-associated (CA)-MRSA infections.

Although healthcare and community MRSA appear distinct in their clinical, microbiologic, and genetic characteristics, the surveillance activities for both are integrated. 

Surveillance for MRSA has traditionally been performed in hospitals and other healthcare settings, and rates calculated among patients at single institutions.1 However, with the emergence of MRSA as a community pathogen, there is now a rationale for performing surveillance on a community-wide basis, so that population-based rates of disease can be determined.

For more information on MRSA, please visit the following CDC websites: CDC HA-MRSA Site, CDC CA-MRSA Site, The National MRSA Education Initiative

1. Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Tolson JS, Martone WJ, National Nosocomial Infections Surveillance System. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991
Image courtesy of the CDC Public Health Image Library

Maryland Emerging Infections Program/ABCs
Johns Hopkins University Bloomberg School of Public Health
Candler Building
111 Market Place, Suite 850, Room 8546
Baltimore, MD 21202
Phone: 410-223-1810
Fax:  410-223-1815
Email: mdabcs@jhsph.edu

back Back|top Top | Print Version
Links marked with This is a .pdf file and requires Acrobat Reader are PDF. Download Adobe Acrobat Reader for viewing .pdf files
Search our Site

View this page in


Community Health Administration

Home | Site Map | Factsheet Index
Local Health Departments | Contact

Site Use Policies

To address technical problems or make suggestions regarding this site please contact us.

TTY Number: 1-800-735-2258 | General Information (410) 767-6742

Community Health Administration
Maryland Department of Health & Mental Hygiene

COPYRIGHT © 1999-2002 Community Health Administration and it's licensors. All Rights Reserved
External Links Disclaimer